Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07811895
NA

Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

Sponsor: RenJi Hospital

View on ClinicalTrials.gov

Summary

To evaluate the efficacy and safety of Dual GIP/GLP-1 receptor agonist pretreatment on reproductive outcomes in obese women before frozen embryo transfer.

Official title: Dual Glucose-dependent Insulinotropic Peptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonist in Women With Obesity for Frozen Embryo Transfer (FET): Pragmatic, Multicenter, Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

20 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

1510

Start Date

2026-09

Completion Date

2030-12

Last Updated

2026-09-10

Healthy Volunteers

No

Interventions

DRUG

Dual GIP/GLP-1 receptor agonist

16 weeks treatment

Locations (1)

RenJi Hospital

Shanghai, Shanghai Municipality, China